Clinical trial
A Phase III Clinical Trial to Compare Ivabradine Versus Digoxin in the Heart Rate Control in Patients With Permanent Atrial Fibrillation Under Treatment With Beta-blockers or Calcium Antagonists.
NCT03718273 is registered in ClinicalTrials.gov with Adolfo Fontenla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Clinical Trial to Compare Ivabradine Versus Digoxin in the Heart Rate Control in Patients With Permanent Atrial Fibrillation Under Treatment With Beta-blockers or Calcium Antagonists.
- Lead sponsor
- Adolfo Fontenla
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 19, 2018
- Completion date
- June 30, 2022
- Enrollment
- 68 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.